Company Quick10K Filing
Bionik Laboratories
10-Q 2019-12-31 Filed 2020-02-14
10-Q 2019-09-30 Filed 2019-11-14
S-1 2019-09-16 Public Filing
10-Q 2019-06-30 Filed 2019-08-12
10-K 2019-03-31 Filed 2019-07-01
10-Q 2018-12-31 Filed 2019-02-11
S-1 2018-10-29 Public Filing
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-14
10-K 2018-03-31 Filed 2018-06-27
10-Q 2017-12-31 Filed 2018-02-13
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-14
10-K 2017-03-31 Filed 2017-06-29
10-Q 2016-12-31 Filed 2017-02-14
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-K 2015-12-31 Filed 2016-03-18
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-04-15
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-06
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-08-07 Filed 2012-08-07
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-04-11
10-Q 2011-09-30 Filed 2011-11-21
8-K 2020-05-18 Leave Agreement
8-K 2020-05-06 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2020-03-23 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2020-02-14 Earnings, Exhibits
8-K 2020-01-30 Regulation FD, Exhibits
8-K 2020-01-22 Enter Agreement, Leave Agreement, Shareholder Vote, Other Events, Exhibits
8-K 2019-11-15 Regulation FD, Exhibits
8-K 2019-10-14 Regulation FD, Exhibits
8-K 2019-09-24 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-09-03 Enter Agreement, Officers, Regulation FD, Exhibits
8-K 2019-08-13 Earnings, Exhibits
8-K 2019-08-01 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2019-07-25 Enter Agreement, Off-BS Arrangement, Sale of Shares, Officers
8-K 2019-07-17 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2019-07-12 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2019-07-08 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2019-06-27 Enter Agreement, Earnings, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-06-18 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2019-06-11 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-05-28 Other Events, Exhibits
8-K 2019-05-15 Officers
8-K 2019-05-13
8-K 2019-05-08 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2019-03-28 Sale of Shares
8-K 2019-03-18 Shareholder Vote
8-K 2019-02-13 Enter Agreement, Exhibits
8-K 2019-02-11 Earnings, Exhibits
8-K 2019-01-23 Regulation FD, Exhibits
8-K 2019-01-22 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2019-01-04 Regulation FD, Exhibits
8-K 2018-12-18 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2018-12-14 Enter Agreement, Other Events, Exhibits
8-K 2018-11-13 Earnings, Exhibits
8-K 2018-10-31 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2018-10-30 Regulation FD, Exhibits
8-K 2018-10-26 Shareholder Rights, Amend Bylaw, Other Events, Exhibits
8-K 2018-10-22 Officers, Other Events, Exhibits
8-K 2018-10-10 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2018-09-07 Officers, Other Events, Exhibits
8-K 2018-08-14 Earnings, Exhibits
8-K 2018-08-07 Shareholder Vote
8-K 2018-08-01 Officers
8-K 2018-07-20 Sale of Shares
8-K 2018-07-16 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2018-07-09 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2018-06-28 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2018-06-27 Earnings, Exhibits
8-K 2018-06-22 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2018-06-21 Regulation FD, Exhibits
8-K 2018-06-11 Enter Agreement, Officers, Exhibits
8-K 2018-06-11 Enter Agreement, Off-BS Arrangement, Sale of Shares, Amend Bylaw, Exhibits
8-K 2018-05-24 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-05-16 Regulation FD, Exhibits
8-K 2018-05-10 Enter Agreement, Off-BS Arrangement
8-K 2018-04-26 Enter Agreement, Off-BS Arrangement
8-K 2018-04-20 Officers
8-K 2018-04-12 Enter Agreement, Off-BS Arrangement, Officers, Exhibits
8-K 2018-03-29 Enter Agreement, Off-BS Arrangement, Sale of Shares, Control, Other Events, Exhibits
8-K 2018-03-22 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2018-03-14 Officers, Other Events, Exhibits
8-K 2018-03-08 Enter Agreement, Leave Agreement, Off-BS Arrangement, Sale of Shares, Officers, Exhibits
8-K 2018-03-06 Enter Agreement, Other Events, Exhibits
8-K 2018-02-09 Enter Agreement, Off-BS Arrangement, Sale of Shares, Other Events, Exhibits
8-K 2018-01-30 Enter Agreement, Off-BS Arrangement, Other Events, Exhibits
8-K 2018-01-24 Officers, Other Events, Exhibits
8-K 2018-01-19 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2018-01-09 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2017-12-29 Enter Agreement, Off-BS Arrangement, Sale of Shares

Bionik Laboratories Financials

BNKL Metrics, Comps, Filings

Quarterly | Annual

Business

Bionik Laboratories Corp. is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and innovative robotics technology to help individuals from hospital to home to regain mobility, enhance autonomy, and regain self-esteem.

The Company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver greater recovery for patients with neurological or mobility impairments. These technologies allow large amounts of data to be collected and processed in real-time, enabling appropriately challenging and individualized therapy during every treatment session. This is the foundation of the InMotion™ therapy. The Company's rehabilitation therapy robots are built on an artificial intelligence platform, measuring the position, the speed and the acceleration of the patient 200 times per second. The artificial intelligence platform is designed to adapt in real time to the patient's needs and progress while providing quantifiable feedback of a patient's progress and performance, in a way that the Company believes a trained clinician cannot.

Based on this foundational work, the Company has a portfolio of products focused on upper and lower extremity rehabilitation for stroke and other mobility-impaired individuals, including three InMotion™ robots currently in the market and two products in varying stages of development.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Powerbridge Technologies (PBTS) 24,514 0% 27,768 21,342 0 0 0 0 19,495
Grom Social Enterprises (GRMM) 24,371 54% -8.0 -19% 19,218 13,325 6,276 3,382 -3,636 -2,971 23,788
Invesco DB G10 Currency Harvest Fund (DBV) 24,330 25.1 4% 24,510 20 0 0 971 971 24,330
Nexien BioPharma (NTVA) 24,293 -5.7 -2,063% 206 22 0 0 -4,245 -4,245 24,222
Petrolia Energy (BBLS) 23,993 0% -0.8 -254% 12,678 4,784 1,119 0 -32,159 -31,671 24,706
BlackRidge Technology (BRTI) 23,968 100% -2.4 -206% 11,365 25,437 298 297 -23,371 -10,074 23,759
Lifeloc Technologies (LCTC) 23,947 47% 25.4 4% 9,024 2,457 6,665 3,152 401 883 22,405
Sierra Monitor (SRMC) 23,849 59% 29.1 3% 11,778 2,813 17,068 10,151 301 742 21,593
Heritage Global (HGBL) 23,776 0% 5.4 15% 22,548 11,416 20,597 0 3,322 3,704 19,875
Standard Metals Processing (SMPR) 23,655 -790.6 -24% 3,905 20,231 0 0 -941 -30 23,653
Bionik Laboratories (BNKL) 23,610 7.9 6% 35,234 3,260 0 1,857 2,167 2,391 18,935
Znergy (ZNRG) 23,572 14% -7.3 -336% 1,025 1,831 1,222 173 -3,443 -3,246 23,566
Draper Oakwood Technology Acquisition (DOTA) 23,547 -218.6 -0% 58,936 53,936 0 0 -160 -108 23,539
Barington/Hilco Acquisition (BHAC) 23,189 -6.7 -22% 9,481 4,481 0 0 -2,081 -2,081 13,844
MamaMancini's Holdings (MMMB) 23,106 32% 21.1 11% 10,462 10,399 24,731 7,963 1,123 1,303 27,501
Nukkleus (NUKK) 23,049 2% -46.5 -136% 324 1,307 19,200 300 -439 -495 23,040
Astro Aerospace (ASDN) 23,044 -3.2 759,640,700% 0 0 -7,596 -7,143 23,019
Blue Eagle Lithium (BEAG) 23,028 -51.1 -47% 967 634 0 0 -451 -451 23,027
GB Sciences (GBLX) 22,981 -23% -1.8 -56% 29,840 15,525 3,909 -891 -16,597 -12,951 23,417
Reviv3 Procare (RVIV) 28,900 44% -191.0 -20% 741 64 993 440 -150 -150 28,554

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash8121116125123467936,1259,0787,8596,6175,3822,7501,6775815448461369995079609603063754475304,675
Accounts Receivable0012094254384135373072133703705181,5211,5231,027481
Inventory2602941952282562313022371561561933364065821,037
PP&E143179178183186424339371595611612612617625625630643718761810
Assets8121116125123467936,4269,5498,4287,2386,23731,37630,34929,31628,96928,89327,95929,03928,58529,08429,08428,90031,02330,67830,23135,234
Accounts Payable2091971311353213774204057858919577957257367369061,3941,1491,0551,434
Long-Term Debt066603263281,454
Liabilities666762071014172224435422302506,2605,9737,4125,3915,0025,7786,3667,08510,3088,1225,1425,1422,0036,3183,2704,6563,260
Stockholders' Equity2649630-5-7-10-11-14-16-395,8849,3198,17997826423,96424,95824,31423,19122,52720,87318,73120,46323,94223,94226,89724,70527,40825,57531,975
Income Statement ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue41511222222164183721888222261417
Cost of Revenue5912335-1729608822525325338445054333683
Gross Profit1056383558162173192248248163480725454198
R&D436610768-3243444188145728606868305468786776776797791,040817886
SG&A2630134734253181683243721,3631,4391,3867657871,5971,0731,9411,2161,3451,5221,5221,3591,5371,8141,4251,785
Tax00000000000
Net Income1-5-21-12-3-6-2-3-1-4-1-24-1,247-2,419-1,177-761-1,004-2,323-589-811-1,532-2,245-3,611-2,581-6,189-761-7615,5053,4292,121-3,383
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-4-2-11-411-13-1-1-0-11-825-1,458-1,066-1,240-1,038-2,898-2,926-1,577-1,451-1,307-2,156-2,495-2,421-2,421-2,390-1,353-1,324-3,427
Cash Investing000-39-175-149-17-1970190-3-161-160-4-8-8-6-76-43-48
Cash Financing9000001423256,7894,5520002672674831,5751,6253,0182,0082,8812,8811,7421,5001,4507,620